Thyroid Hormone Synthesis, Regulation, and Systemic Effects

Thyroid Hormone: Synthesis, Regulation, and Effects

  • Overview of the HPT axis

    • Hypothalamus → releases TRH (thyrotropin-releasing hormone)

    • Anterior pituitary → releases TSH (thyroid-stimulating hormone)

    • Thyroid gland → produces thyroid hormones T4 (thyroxine) and T3 (triiodothyronine)

    • Target tissues respond to thyroid hormones; negative feedback loops regulate the axis

    • Peripheral conversion also contributes to active T3 levels

  • Key thyroid hormone concepts

    • T4 is the primary hormone secreted by the thyroid; T3 is more active at receptors

    • T3 is produced largely by deiodination of T4 in peripheral tissues; a portion is produced within the thyroid

    • Reverse T3 (rT3) is an inactive isomer formed by deiodination

    • The activity of thyroid hormone depends on receptor binding and subsequent genomic effects

  • Anatomy related to thyroid hormone production

    • Thyroid gland is located in the front of the neck, wrapping around the trachea

    • Parathyroid glands lie on the posterior surface and regulate calcium via PTH (context for this lecture)

  • Thyroid hormone synthesis and storage in the thyroid

    • Thyroid follicles are lined by follicular epithelial cells surrounding a colloid-filled lumen

    • Colloid stores thyroglobulin (TG), a large glycoprotein rich in tyrosines, where hormone synthesis occurs

    • Storage is significant: even with reduced iodine intake, there is a large colloid reservoir delaying immediate deficiency

    • Core dietary requirement: iodine

    • TG contains tyrosine residues that become iodinated to form MIT and DIT units

  • Iodine uptake and organification (colloid formation)

    • Dietary iodine is absorbed and transported into follicular cells via the Na^+/I^- symporter (NIS)

    • Iodine is moved into the colloid by transporters on the apical membrane (e.g., pendrin-like pathways)

    • Within the colloid, thyroid peroxidase (TPO) uses hydrogen peroxide (H2O2) to oxidize iodide and organify it onto tyrosine residues of thyroglobulin

    • MIT = monoiodotyrosine; DIT = diiodotyrosine

    • Coupling steps within thyroglobulin form T4 (DIT+DIT) and T3 (MIT+DIT)

    • The general scheme within TG:

    • MIT + DIT → T3

    • DIT + DIT → T4

    • The iodinated thyroglobulin complex is stored in colloid until needed

  • Endocytosis and release of thyroid hormones

    • Colloid thyroglobulin is endocytosed back into follicular cells

    • Proteolysis of thyroglobulin releases T4 and T3 into the bloodstream

    • T4 is predominantly secreted; some T3 is secreted directly from thyroid

    • Thyroid hormone precursors and degradation products can be recycled

    • Storage in colloid can support months of hormone supply; secretion is pulsatile and dependent on iodine availability and TG processing

  • Transport and cellular entry of thyroid hormones

    • In blood, thyroid hormones travel largely bound to transport proteins; a small free fraction is biologically active

    • Transport into target cells requires specific transporters (e.g., MCT8, organic anion transporters)

    • Some hormone is activated locally in tissues by deiodinases before acting on nuclear receptors

  • Peripheral activation: deiodinases

    • Deiodinase types and roles

    • D1 and D2: activating deiodinases; convert T4 → active T3 (and can convert rT3 → T2 in some contexts)

    • D3: inactivating deiodinase; converts T4 → rT3 (inactive) and T3 → T2

    • Local tissue specificity determines where T4 is converted to T3 and thus where thyroid hormone effects occur

    • Schematic reactions:

    • extT<em>4ightarrowextT</em>3extviaD1extorD2ext{T}<em>4 ightarrow ext{T}</em>3 ext{ via } D1 ext{ or } D2

    • extT<em>4ightarrowextrT</em>3extviaD3ext{T}<em>4 ightarrow ext{rT}</em>3 ext{ via } D3

    • extT<em>3ightarrowextT</em>2extviaD1extorD2ext{T}<em>3 ightarrow ext{T}</em>2 ext{ via } D1 ext{ or } D2

    • Tissue-specific expression of deiodinases (e.g., skeletal muscle, brain, liver, adipose tissue, kidney) determines local T3 availability

  • Thyroid hormone receptors and genomic action

    • T3 binds to thyroid hormone receptors (TRs), typically forming a heterodimer with the retinoid X receptor (RXR)

    • The receptor complex binds to the Thyroid Response Element (TRE) in DNA and regulates transcription

    • In many cells, the receptor complex already sits on DNA and is modulated by hormone binding to recruit coactivators or release corepressors

    • Genomic effects include upregulation or downregulation of target gene transcription that governs metabolism, growth, and development

    • Core downstream targets include receptors, metabolic enzymes, and components of signaling pathways that influence energy use

  • Immediate versus long-term effects of TR signaling

    • Immediate response via non-genomic pathways can alter ion transport and enzyme activity (in some contexts not central in this lecture)

    • Genomic effects drive long-term changes in metabolism, growth, and development

  • Physiologic and systemic effects of thyroid hormone

    • Metabolic effects: regulates carbohydrate, fat, and protein metabolism; increases overall basal metabolic rate

    • Growth and development: essential for normal growth; in utero neural development requires maternal and fetal thyroid hormone

    • Cardiovascular effects: increases cardiac output and heart rate; increases blood volume and responsiveness to catecholamines

    • Nervous system and development: thyroid hormone is critical for neural development; hypothyroidism during development can cause irreversible cognitive impairment

    • Permissive action: thyroid hormone enhances tissue responsiveness to catecholamines (epinephrine/norepinephrine) by upregulating adrenergic receptors and/or signaling components

  • Developmental and clinical implications

    • In utero hypothyroidism or maternal hypothyroidism can lead to impaired neural development and potential mental retardation if untreated

    • Postnatal thyroid hormone deficits can cause growth retardation and development delays; timely thyroid hormone replacement can allow catch-up growth in some cases

    • Hyperthyroidism can cause increased metabolism, weight loss, and heightened sympathetic activity; hypothyroidism causes slowed metabolism, weight gain, and reduced energy

  • Diagnostic and clinical management principles

    • Common clinical assessment uses measurement of TSH and free T4 (and sometimes free T3) to classify thyroid states

    • Primary hyperthyroidism: high thyroid hormones with low TSH (negative feedback is active)

    • Primary hypothyroidism: low thyroid hormones with high TSH

    • Secondary (pituitary) or tertiary (hypothalamic) disturbances may show discordant TSH and thyroid hormone levels

    • Treatment approaches include restoring euthyroidism with levothyroxine (synthetic T4) in hypothyroidism and using antithyroid drugs or radioactive iodine for hyperthyroidism; surgical options in select cases

    • Radioactive iodine therapy can ablate residual thyroid tissue after cancer surgery to reduce recurrence risk

    • In thyroid cancer management, radioactive iodine uptake helps destroy remaining thyroid cells while minimizing systemic exposure

  • Thyroid cancer and iodine handling

    • Thyroid cells take up iodine actively, which enables targeted radioactive iodine therapy to destroy residual or metastatic thyroid cancer cells

    • Iodized salt is a public health measure to prevent iodine deficiency in developed regions

    • In populations with low iodized salt intake or dietary changes, iodine deficiency can re-emerge as a public health issue

  • Iodine intake and systemic considerations (numerical notes)

    • Typical dietary iodine intake example: about 400 extµg/day400 \, ext{µg/day}

    • Of this, roughly 320 extµg/day320 \, ext{µg/day} is excreted in urine, leaving about 80 extµg/day80 \, ext{µg/day} for thyroid uptake and tissue use

    • Storage within colloid provides a buffer that can maintain thyroid hormone levels for weeks to months if intake is reduced

    • Iodine sufficiency is critical for normal synthesis and to avoid goiter and hypothyroidism

  • Thyroid hormone dynamics: synthesis, secretion, and turnover (summary numbers)

    • Thyroid gland produces T4 predominantly; T3 is produced in the thyroid and via peripheral conversion

    • Peripheral conversion of T4 to T3 maintains active hormone supply; rT3 represents inactive deiodination products

    • Plasma dynamics:

    • T4 pool: relatively large; half-life t1/2ext(T4) ≈ 7 dayst_{1/2} ext{(T4)} \,\approx\, 7\ \text{days}; clearance around ∼1 L/day\sim 1\ \text{L/day}

    • T3 pool: smaller; half-life t1/2≈1 dayt_{1/2} \approx 1\ \text{day}; clearance around ∼20−26 L/day\sim 20-26\ \text{L/day}

    • These pharmacokinetics underpin replacement therapy strategies and interpretation of lab tests

  • A note on terminology and key components

    • MIT = monoiodotyrosine; DIT = diiodotyrosine

    • D1, D2 = activating deiodinases (generate T3 from T4)

    • D3 = inactivating deiodinase (generates rT3 from T4 or T2 from T3)

    • NIS = sodium-iodide symporter

    • TG = thyroglobulin

    • TPO = thyroid peroxidase

    • TRE = thyroid response element

    • RXR = retinoid X receptor (forms heterodimer with TR)

  • Conceptual model: what to remember for exams

    • The thyroid gland is the sole source of the T4 pool; most T3 activity in tissues comes from peripheral conversion of T4 by deiodinases

    • T3 is the primary active ligand at thyroid hormone receptors

    • Deiodinases in different tissues tailor local T3 availability and thus tissue-specific effects

    • Thyroid hormone effects are broad and include metabolic rate, growth, development, and cardiovascular readiness to respond to catecholamines

    • Proper iodine intake and thyroid hormone synthesis are essential for normal neurological development and metabolic health

  • Quick connections to broader physiology

    • Interactions with the autonomic nervous system: thyroid hormone increases adrenergic receptor density and responsiveness (permissive effect)

    • Growth and development require adequate thyroid hormone signaling; deficits during critical windows can cause lasting deficits

    • The endocrine axis involves tight feedback: T4/T3 inhibit TRH and TSH production, maintaining homeostasis

  • Wednesday preview (context for upcoming topics)

    • Discussion of hypohyroidism and hyperthyroidism with extended reading and paper discussion

    • Deeper dive into molecular signaling downstream of TRH/TSH and thyroid hormone receptors